Economist Warns Against "Euro" Regulation of US Pharmacies

Ken Rankin
Published Online: Thursday, July 1, 2004

The solution to rising prescription drug prices in the United States does not involve adopting the kind of anti-competitive regulations imposed on retail pharmacies in other countries, American Enterprise Institute economist John E. Calfee told Congress. He cited research that suggests that heavy-handed "regulation of retail pharmacy further constrains competition in France, Germany, and Italy."

Calfee told a Senate Finance Subcommittee that these studies indicate that "anticompetitive regulations in European nations often increase retail prices on the order of 15% or more." He singled out Germany as a prime example, noting that pharmacy retail margins in that country are fixed by the government, prescription price discounts are prohibited, and restrictions are placed on the entry of competing pharmacies.

Europe is not alone in fostering anticompetitive restrictions on community pharmacies, Calfee added. "Australian authorities recently refused to reconsider regulations that restrict competition so as to increase pharmacy prices by 15%," he said.

Latest Articles
Pharmacists might be surprised to learn that Pinterest is a hotbed for anti-vaccine sentiment.
The FDA has approved betamethasone dipropionate spray, 0.05%, as a treatment for mild to moderate plaque psoriasis in patients aged 18 years and older.
Medication errors injure thousands of patients annually, and while mistakes occur with all medication classes, those involving antiretroviral therapies are particularly troublesome.
Acute respiratory infections such as the common cold are often accompanied by cough and congestion caused by mucus hypersecretion.
Latest Issues